In this POV, we explain what’s most important for you to know, recommend ways that you can stay ahead of the curve, and provide links to additional reading.
Many pharma executive and marketing leaders actively monitor the pricing transparency conversation in search of the meaningful insights that can truly impact their business performance. And while much public attention has been paid to items such as “drug costs in TV commercials” and “CEO testimony before Congress,” little evidence exists
In the world of pharma, spillover refers to instances in which healthcare providers (HCPs) alter their prescribing behavior in response to -- sometimes inaccurate -- perceptions of restricted access, or perhaps in response to patient complaints about co-pay burden or drug pricing. Learn about what's needed to predict spillover and avoid the problems that come with it.
In 1999, while the sweet sound of a dial-up modem accompanied our forays into the World Wide Web, Faruk Capan was taking a risk in Kansas City. It wouldn’t be his first, or his last. Raised in Istanbul, Turkey, Faruk came to Missouri for graduate studies, and then took an
It’s been a big year for Intouch: We’ve been celebrating our 20th anniversary for months; we opened an office in Boston this past spring, and now we’ve put down roots on the West Coast, with two new offices in San Francisco and San Diego!
Another Digital Pharma East (DPE) is on the books, and yes, it’s true: DPE was about a month ago, but what we learned is still worth talking about. Check out what Intouch found most interesting at DPE 2019.
We recently sat down with three Intouch experts – Chastity Spencer, Associate Media Director; Antonio Rivera, Associate Director, Inclusion & Diversity; and Chanel Hemphill, Senior Marketing Strategists – to get their thoughts on what brands need to know about the importance of developing marketing messages that speak to all kinds
Pharma marketing still has a ways to go when it comes to matching itself to our multicultural reality, as we pointed out recently in this piece on diversity and inclusion (and offered some suggestions on how to do it well). Particularly in a country that's increasingly “majority-minority” (Americans age 15
As we edge closer to the end of 2019, we wanted to stop and smell the roses, or in this case, indulge in a Throwback Thursday moment and share some of our favorite blog posts from this year. This list represents Intouch’s thinking on a range of topics, from the
Drug pricing is a hot button issue, including the pricing transparency battle, and it's not going away anytime soon. On July 8, U.S. District Court Judge Amit Mehta ruled that the Department of Health and Human Services had overstepped its authority in requiring pricing disclosures, stating, “That policy very well